BORDENTOWN TOWNSHIP, NJ— The Bordentown Township Planning Board unanimously gave the go-ahead for a medical marijuana dispensary to be built on Route 130 at its meeting on Thursday night.
Curaleaf, a Massachusetts-based company that serves more than 350,000 registered patients in twenty-three states around the country, got preliminary and final site plan approval on its proposal to open a location at 191 Route 130 North.
Sign Up for Bordentown Newsletter
Our newsletter delivers the local news that you can trust.
You have successfully signed up for the TAPinto Bordentown Newsletter.
The Bordentown site will be for retail sales only, and that cultivation, manufacturing and packaging would not occur there. Curaleaf executives have said that the product delivered to the Bordentown site would be completely secure, packaged and in final-sales format, and that the company meets and even exceeds standards of procedures set by the state of New Jersey.
At Thursday night’s meeting, Chris Melillo, Curaleaf’s Senior Vice President of Retail operations, also detailed the ways the company secures its inventory. Calling their procedures “100 percent controlled”, Melillo noted that its product is held in a “DEA cage” and that employees must electronically enter the cage, so Curaleaf knows who enters, and when, at all times. The proposed site will have significant camera placement in all areas of the building and property, most especially at controlled access points. Futhermore, their inventory is tracked by a “seed to sale” biotrack system, so that Curaleaf knows where its entire inventory is at all times, even after it is sold to a customer. Melillo also said that Curaleaf would be hiring a full-team of security officers,